168 related articles for article (PubMed ID: 27530054)
1. Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.
Lokhandwala T; Bittoni MA; Dann RA; D'Souza AO; Johnson M; Nagy RJ; Lanman RB; Merritt RE; Carbone DP
Clin Lung Cancer; 2017 Jan; 18(1):e27-e34. PubMed ID: 27530054
[TBL] [Abstract][Full Text] [Related]
2. Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.
Roth JA; Sullivan SD; Goulart BH; Ravelo A; Sanderson JC; Ramsey SD
J Oncol Pract; 2015 Jul; 11(4):267-72. PubMed ID: 25943596
[TBL] [Abstract][Full Text] [Related]
3. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
4. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.
Marcus C; Paidpally V; Antoniou A; Zaheer A; Wahl RL; Subramaniam RM
J Nucl Med; 2015 Feb; 56(2):204-8. PubMed ID: 25613535
[TBL] [Abstract][Full Text] [Related]
6. Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.
Dinan MA; Curtis LH; Carpenter WR; Biddle AK; Abernethy AP; Patz EF; Schulman KA; Weinberger M
J Thorac Oncol; 2014 Apr; 9(4):512-8. PubMed ID: 24736074
[TBL] [Abstract][Full Text] [Related]
7. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
[TBL] [Abstract][Full Text] [Related]
9. Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy.
Harewood GC; Wiersema MJ; Edell ES; Liebow M
Mayo Clin Proc; 2002 Feb; 77(2):155-64. PubMed ID: 11838649
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of CT screening in the National Lung Screening Trial.
Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
[TBL] [Abstract][Full Text] [Related]
11. Point: Should lung cancer screening by chest CT scan be a covered benefit? Yes.
Yankelevitz DF
Chest; 2015 Feb; 147(2):287-289. PubMed ID: 25412275
[No Abstract] [Full Text] [Related]
12. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
13. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting.
Huo J; Xu Y; Sheu T; Volk RJ; Shih YT
JAMA Intern Med; 2019 Mar; 179(3):324-332. PubMed ID: 30640382
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
[TBL] [Abstract][Full Text] [Related]
15. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
[TBL] [Abstract][Full Text] [Related]
16. Timeliness of Recommended Follow-Up After an Abnormal Finding on Diagnostic Chest CT in Smokers at High Risk of Developing Lung Cancer.
Percac-Lima S; Ashburner JM; Shepard JA; Lennes IT; Rimmelin DE; Atlas SJ
J Am Coll Radiol; 2016 May; 13(5):497-504. PubMed ID: 26924163
[TBL] [Abstract][Full Text] [Related]
17. Cost of illness associated with metastatic breast cancer.
Rao S; Kubisiak J; Gilden D
Breast Cancer Res Treat; 2004 Jan; 83(1):25-32. PubMed ID: 14997052
[TBL] [Abstract][Full Text] [Related]
18. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis?
Starnes SL; Reed MF; Meyer CA; Shipley RT; Jazieh AR; Pina EM; Redmond K; Huffman LC; Pandalai PK; Howington JA
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):688-93. PubMed ID: 20933243
[TBL] [Abstract][Full Text] [Related]
19. Gaps in Guideline-Concordant Use of Diagnostic Tests Among Lung Cancer Patients.
Flanagan MR; Varghese TK; Backhus LM; Wood DE; Mulligan MS; Cheng AM; Flum DR; Farjah F
Ann Thorac Surg; 2015 Dec; 100(6):2006-12. PubMed ID: 26507425
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
